DermagridTM, a “first-in-class” wound healing product to treat diabetic foot ulcers.


MxBiodevices is commercializing a patented injectable bioscaffold, “DermagridTM”, for the treatment of chronic dermal wounds including diabetic foot ulcers (DFUs), decubitus ulcers (bed sores), venous stasis ulcers (lower leg) and surgical adhesions.


Wound treated three times with Apligraf® and once with Regranex® without healing the wound.

Wound healed at 20 weeks after just 2 injections of DermagridTM.

Caution: DermagridTM is an investigational device, limited by law to investigational use only.